BELKYRA ® A treatment to improve the appearance of a double chin
|
Double chin defined
Fullness under the chin or a ‘double-chin’ is a common concern for both men and women. It can be caused by ageing, genetics or weight changes. Sometimes, no matter how much you diet or exercise, the fullness in this area may not go away – and it may make you feel like you look older and heavier than you actually are. BELKYRA ® is an injectable treatment that improves the appearance of a double chin.
The active ingredient in BELKYRA® breaks down the fat cells. Once broken down, fat cells can no longer store or accumulate fat. More than 75% of BELKYRA® patients reported satisfaction with the appearance of their face and chin. Based on their chin profile, BELKYRA ® patients reported feeling:
|
The exciting launch of BELKYRA ® is taking place in New Zealand on Thursday 22 February. The Vein and Skin Clinic are pleased to be offering this treatment to our patients. Consultations and treatments will be available after this date. |
Disclaimer.
You will need to pay for this medicine and the doctor’s consultation.
BELKYRA® injection (deoxycholic acid 10 mg/mL) is a Prescription Medicine used for the improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. It should be administered only by trained medical professionals. BELKYRA® has risks and benefits. For more information, talk to your healthcare professional or read the Consumer Medicine Information available at www.medsafe.govt.nz.
Ask your specialist if BELKYRA® is right for you. Always follow your specialist’s instructions. If you experience side effects and they concern you, see your healthcare professional. You will need to pay for BELKYRA®. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine.
Note: Results from BELKYRA® treatment usually last up to four years.
BELKYRA® and its design are trademarks of Kythera Biopharmaceuticals, Inc., an Allergan affiliate. ™Trademark of Allergan, Inc. Allergan Australia Pty Ltd, 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831. Allergan New Zealand Limited, Auckland. © 2018 Allergan.
You will need to pay for this medicine and the doctor’s consultation.
BELKYRA® injection (deoxycholic acid 10 mg/mL) is a Prescription Medicine used for the improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. It should be administered only by trained medical professionals. BELKYRA® has risks and benefits. For more information, talk to your healthcare professional or read the Consumer Medicine Information available at www.medsafe.govt.nz.
Ask your specialist if BELKYRA® is right for you. Always follow your specialist’s instructions. If you experience side effects and they concern you, see your healthcare professional. You will need to pay for BELKYRA®. Normal Doctors visit fees apply. BELKYRA® treatment should be administered only by trained medical professionals. Speak to your specialist about your own situation and about the benefits/risks of this procedure in appearance medicine.
Note: Results from BELKYRA® treatment usually last up to four years.
BELKYRA® and its design are trademarks of Kythera Biopharmaceuticals, Inc., an Allergan affiliate. ™Trademark of Allergan, Inc. Allergan Australia Pty Ltd, 810 Pacific Highway, Gordon NSW 2072. ABN 85 000 612 831. Allergan New Zealand Limited, Auckland. © 2018 Allergan.
|
Book A ConsultationTo book a consultation with our doctor (fees apply) please Contact Us through our enquiry form or by phoning Vein & Skin Clinic on 0800 639 968.
|
